Score Improvement
Inolex conducted a mid-year reporting assessment with Ecovadis to demonstrate the progress we have made in our sustainability initiatives. The result of the evaluation was a score increase of 8 points, raising the company's status from bronze to silver.
The silver medal represents the 73rd percentile of businesses. Inolex received a score of 50/100 or more for each of the categories rated: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
Ecovadis Business Sustainability Ratings
Ecovadis is a widely recognized platform for assessing companies' sustainability practices, actions, results, and policies. It is applicable to all company types and the assessment is tailored to the company depending on industry, size, and other factors. It is one tool, built on globally-recognized standards, that evaluates sustainability through a meticulous process resulting in a tangible score as well as a detailed report of strengths and improvement areas.
Progress & Goals
Inolex is a designer of sustainable ingredients for health, beauty, and wellness. Our products enable safe formulations with less environmental impact. Corporate Sustainability relies on rigorous tracking, reporting and demonstration of progress. We aim to raise our Corporate Sustainability Program to the level of our sustainable products. Our goal is to reach Ecovadis Platinum by 2025 through policy improvements, forward actions, and increased tracking & reporting.
Related Articles
Inolex Defends Ingredient Innovation with Legal Action
October 2024
Inolex is taking decisive legal action to protect its innovative ingredient technologies and uphold the integrity of its product offerings.
Inolex granted patents for Cationic Amino Lipid Technology
February 2024
Bringing the most advanced, sustainable conditioning ingredients on the market to Korea and Brazil
Inolex granted European patent for safe, sustainable Preservation Technology
February 2024
Building on its safe and sustainable preservation platform with a newly issued European patent EP3075401B1 and the launch of Spectrastatâ„¢ CHA.